Which of the following tissue inflammation is treated by administering the drug Balsalazide?

RRB Nsg. Superintendent - 29 April 2025 (Shift-3rd)

Pharmacology

Easy

Appeared in: RRB Nsg. Superintendent - 29 April 2025 (Shift-3rd)

Explanation

Balsalazide is specifically designed to treat inflammation of the bowel mucosa, particularly in the colon.
It is a prodrug, meaning it is inactive until it reaches its target site.
In the colon, gut bacteria cleave an azo bond in the drug's structure, releasing the active anti-inflammatory component, 5-aminosalicylic acid (5-ASA).
This mechanism ensures targeted drug delivery directly to the site of inflammation in the bowel, minimizing systemic side effects.

Option A: Balsalazide does not treat inflammation of the renal (kidney) mucosa. Aminosalicylates can rarely cause kidney damage, so renal function is monitored during therapy.
Option C: The olfactory mucosa is in the nasal cavity and is responsible for the sense of smell. Balsalazide has no therapeutic effect on this tissue.
Option D: The venereal mucosa refers to the genital tract. Balsalazide is not used to treat sexually transmitted infections or other inflammatory conditions of this area.

Visual 1: Diagram - A flowchart showing the path of a Balsalazide capsule through the GI tract. It would illustrate the drug passing through the stomach and small intestine intact, and then breaking down in the colon to release 5-ASA, highlighting the role of bacterial azo-reductase.

Clinical Relevance

Nursing practice connection: Knowing Pharmacology and therapeutic use of Balsalazide in treating Inflammatory Bowel Disease (IBD) helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
A key nursing responsibility is to educate patients that the goal of Balsalazide is to reduce the symptoms of ulcerative colitis, such as diarrhea, rectal bleeding, and abdominal pain.
Nurses must assess for allergies to salicylates (e.g., aspirin) before administration, as a cross-sensitivity can occur.
Monitoring for therapeutic effectiveness involves checking the frequency and consistency of bowel movements and asking the patient about symptomatic relief.

How to Approach the Question

First, identify the drug mentioned in the question: Balsalazide.
Recall the drug class and its primary indication. Balsalazide is an aminosalicylate (5-ASA) used for inflammatory bowel disease (IBD).
Think about the mechanism of action. Balsalazide is a prodrug designed for targeted delivery to a specific part of the gastrointestinal tract.
Remember that the 'azo' bond in its structure is broken by bacteria in the colon. This tells you its site of action is the colon, which is part of the bowel.
Connect this site of action to the options provided. Inflammation of the colon's lining is inflammation of the 'Bowel mucosa'.
Eliminate the other options as they relate to the kidneys (renal), nose (olfactory), and genital tract (venereal), which are not targets for this GI-specific drug.

Concept Tested & Keywords

Concept Tested: Pharmacology and therapeutic use of Balsalazide in treating Inflammatory Bowel Disease (IBD).
Stem keywords: tissue inflammation, Balsalazide
Lead-in keywords: Which

QuApKjb6aV3tGduyRhA4QB